Cullen/Frost Bankers’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.77K | Hold |
45
| – | – | ﹤0.01% | 1059 |
|
|
2025
Q1 | $7.01K | Buy |
45
+4
| +10% | +$623 | ﹤0.01% | 1001 |
|
|
2024
Q4 | $5.64K | Hold |
41
| – | – | ﹤0.01% | 979 |
|
|
2024
Q3 | $6.12K | Buy |
41
+38
| +1,267% | +$5.67K | ﹤0.01% | 959 |
|
|
2024
Q2 | $409 | Buy |
+3
| New | +$409 | ﹤0.01% | 1213 |
|
|
2024
Q1 | – | Sell |
-100
| Closed | -$12.6K | – | 1001 |
|
|
2023
Q4 | $12.6K | Hold |
100
| – | – | ﹤0.01% | 789 |
|
|
2023
Q3 | $9.36K | Buy |
+100
| New | +$9.36K | ﹤0.01% | 932 |
|